Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 15951-16000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06470919
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NARecruiting
2,700 participants
Started: Nov 6, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors2 locations
NCT06544408
Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation
NARecruiting
132 participants
Started: Nov 6, 2024 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT06358508
Sapphire 3 CTO Study
NARecruiting
170 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2025
8 conditions2 sponsors14 locations
NCT06663358
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT06989255
A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.
N/ARecruiting
3,000 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06155279
Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)
PHASE2Recruiting
40 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors8 locations
NCT06674096
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
PHASE2Recruiting
44 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT06467435
Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)
PHASE1Recruiting
13 participants
Started: Nov 6, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06393868
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
PHASE3Recruiting
360 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2028
3 conditions1 sponsor3 locations
NCT06716125
Lifestyle Changes in Obese Males With Sexual Dysfunction and Tinnitus
NARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Apr 6, 2025
3 conditions1 sponsor1 location
NCT06447987
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
PHASE1Recruiting
24 participants
Started: Nov 6, 2024 · Completed: Dec 5, 2026
2 conditions2 sponsors1 location
NCT06679569
Deep Neuromuscular Blockade on Postoperative Pain
NARecruiting
106 participants
Started: Nov 6, 2024 · Completed: Nov 7, 2026
1 condition1 sponsor1 location
NCT06674473
Evaluation of Long-term Isokinetic Training of Knee Joint
NARecruiting
12 participants
Started: Nov 6, 2024 · Completed: Jul 20, 2025
1 condition2 sponsors1 location
NCT06541158
Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
NARecruiting
76 participants
Started: Nov 6, 2024 · Completed: Feb 28, 2027
1 condition2 sponsors4 locations
NCT06784791
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
PHASE2Recruiting
20 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor4 locations
NCT06912009
Evaluation of the Duration of Obtaining Curative Anticoagulation in Patients With Clinically Significant Pulmonary Embolism in an Intensive Care Unit
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Dec 6, 2025
1 condition1 sponsor1 location
NCT06695910
Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).
PHASE4Recruiting
48 participants
Started: Nov 6, 2024 · Completed: Jun 1, 2026
2 conditions2 sponsors2 locations
NCT06162884
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
N/ARecruiting
200 participants
Started: Nov 6, 2024 · Completed: Aug 19, 2028
1 condition2 sponsors1 location
NCT06806891
Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis
NARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Mar 6, 2025
2 conditions1 sponsor1 location
NCT06596876
A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
PHASE3Recruiting
450 participants
Started: Nov 6, 2024 · Completed: Feb 14, 2027
1 condition1 sponsor1 location
NCT06710288
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
PHASE2Recruiting
20 participants
Started: Nov 6, 2024 · Completed: May 31, 2027
1 condition1 sponsor2 locations
NCT06817525
Nab-P+Cb+PD1 Inhibitors Combined/not Combined with Bevacizumab As Neoadjuvant Therapy for Early TNBC
PHASE2Recruiting
64 participants
Started: Nov 6, 2024 · Completed: Nov 6, 2025
1 condition1 sponsor1 location
NCT06511908
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
PHASE2Recruiting
50 participants
Started: Nov 6, 2024 · Completed: Jul 1, 2027
13 conditions1 sponsor1 location
NCT06616142
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 6, 2024 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT06679829
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
PHASE2Recruiting
215 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2027
1 condition2 sponsors7 locations
NCT06880575
Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
N/ARecruiting
10,139 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06670404
Prospective Evaluation of Therapeutic Combination in Treating Vertebral Compression Fractures
N/ARecruiting
130 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT06774833
Self-initiated Perturbation-based Training in Older Adults
NARecruiting
48 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06750419
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
PHASE3Recruiting
82 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor8 locations
NCT05600920
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
PHASE1/PHASE2Recruiting
60 participants
Started: Nov 6, 2024 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT06584448
Drinking, Acetate, and Stress
NARecruiting
50 participants
Started: Nov 6, 2024 · Completed: Jan 31, 2030
4 conditions2 sponsors2 locations
NCT06699095
Home Rehabilitation As Continuity of Care in MS
NARecruiting
20 participants
Started: Nov 6, 2024 · Completed: Nov 15, 2025
1 condition3 sponsors3 locations
NCT06225986
Living Memory Home-4-Dementia Care Pairs
NARecruiting
70 participants
Started: Nov 6, 2024 · Completed: Jun 16, 2025
1 condition2 sponsors1 location
NCT06560372
Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital
NARecruiting
154 participants
Started: Nov 6, 2024 · Completed: Dec 6, 2028
4 conditions1 sponsor1 location
NCT06706570
PIK3CA Mutational Status Assessment
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06443138
Preparation for Medical and Surgical Procedures in Oncogeriatry.
NARecruiting
20 participants
Started: Nov 6, 2024 · Completed: Nov 10, 2026
1 condition1 sponsor1 location
NCT06454188
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
PHASE4Recruiting
100 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors4 locations
NCT06723093
Evaluation of a Supportive Housing Program for Adults Who Are Unhoused and Have Complex Health Needs
NARecruiting
100 participants
Started: Nov 6, 2024 · Completed: May 1, 2027
1 condition1 sponsor2 locations
NCT06494384
Implementation of Problem-Solving Treatment in Community Health Centers (PST-Aid)
NARecruiting
410 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06941584
Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
N/ARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Jan 6, 2027
1 condition2 sponsors1 location
NCT06594094
An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)
NARecruiting
6 participants
Started: Nov 6, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06566586
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
PHASE2Recruiting
80 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor30 locations
NCT05582993
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
PHASE3Recruiting
24 participants
Started: Nov 6, 2024 · Completed: Apr 11, 2030
1 condition1 sponsor15 locations
NCT06062017
Potassium, Hydration, Cardiovascular, and Kidney Study (PHACKs)
NARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Jul 31, 2027
3 conditions2 sponsors1 location
NCT06781411
Unity Cures Future (UCF) Biobank
N/ARecruiting
10,000 participants
Started: Nov 6, 2024 · Completed: Nov 6, 2075
1 condition1 sponsor1 location
NCT06111313
The University of Miami Adapt (UAdapt) Trial
PHASE2Recruiting
130 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2033
1 condition2 sponsors1 location
NCT06655623
A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-ST*Case
NARecruiting
3 participants
Started: Nov 6, 2024 · Completed: Dec 19, 2026
4 conditions2 sponsors2 locations
NCT05629546
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
PHASE1Recruiting
33 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2030
2 conditions3 sponsors1 location
NCT06488924
An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
PHASE1/PHASE2Recruiting
10 participants
Started: Nov 5, 2024 · Completed: Apr 30, 2030
1 condition1 sponsor3 locations
NCT06767436
A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer
N/ARecruiting
300 participants
Started: Nov 5, 2024 · Completed: Nov 4, 2025
1 condition1 sponsor1 location